Drug Database
Back to search

France· FR:68186732

MOUNJARO 15 mg/dose KwikPen solution injectable en stylo pré-rempli

A tirzepatide product containing tirzépatide, registered in France by ELI LILLY NEDERLAND BV (PAY-BAS), on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A10BX16

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedMOUNJARO 15 mg/dose KwikPen solution …ATCA10BX16REGISTER NO.FR:68186732PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tirzépatideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tirzepatide is registered in 15 of 19 countries.

Countries holding a registration under ATC A10BX16 (tirzepatide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose
Search tirzepatide products by name

Tirzepatide · ATC A10BX16

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tirzepatide costs, country by country.

Normalised to the WHO defined daily dose (1.4 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tirzepatide · price per daily dose (1.4 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$45.12
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TIRZÉPATIDE
Manufacturer
ELI LILLY NEDERLAND BV (PAY-BAS)
Country
France (FR)
ATC code
A10BX16
ATC class
Tirzepatide
Defined daily dose
1.4 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930292976
    1 cartouche en verre multidose(s) de 2,4 mL dans un stylo pré-rempli
    EUR 433.8

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tirzepatide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tirzepatide products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Mounjaro, Mounjaro Kwikpen
  • Liechtenstein · Mounjaro, Mounjaro Kwikpen
  • Norway · Mounjaro, Mounjaro Kwikpen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ae09b8d0-9394-4b89-8996-f3b6b7d3dcc3
GET /v1/drugs/ae09b8d0-9394-4b89-8996-f3b6b7d3dcc3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68186732",
  "date_amm": "2024-04-19",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/22/1685",
  "substance": "TIRZÉPATIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about tirzepatide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console